(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GSTA4 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1320601 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GSTA4 mRNA CTD PMID:22079256 (E)-4-hydroxynon-2-enal affects binding EXP 1641942 (E)-4-hydroxynon-2-enal binds to Gsta4 protein RGD (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of GSTA4 mRNA CTD PMID:9774145 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of GSTA4 mRNA CTD PMID:9774145 (S)-nicotine increases activity EXP 6480464 Nicotine results in increased activity of GSTA4 protein CTD PMID:9774145 1-chloro-2,4-dinitrobenzene affects binding EXP 1641942 1-chloro-2 4-dinitrobenzene binds to Gsta4 protein RGD 1-chloro-2,4-dinitrobenzene affects metabolic processing EXP 6480464 GSTA4 protein affects the metabolism of Dinitrochlorobenzene CTD PMID:2619714 1-chloro-2,4-dinitrobenzene multiple interactions ISO RGD:1320601 6480464 [GSTA1 protein binds to GSTA4 protein] which affects the metabolism of Dinitrochlorobenzene, [GSTA4 protein binds to GSTA4 protein] which affects the metabolism of Dinitrochlorobenzene CTD PMID:11851347 13-oxo-9,11-octadecadienoic acid affects metabolic processing ISO RGD:1320601 6480464 GSTA4 protein affects the metabolism of 13-oxo-9, 11-octadecadienoic acid CTD PMID:12031293 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of GSTA4 mRNA CTD PMID:15212814 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of GSTA4 mRNA CTD PMID:17557909 17beta-estradiol multiple interactions ISO RGD:1320601 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of GSTA4 mRNA CTD PMID:30165855 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of GSTA4 mRNA CTD PMID:32145629 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GSTA4 protein CTD PMID:16548065 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GSTA4 mRNA CTD PMID:16054898 more ... 2-hexenal increases expression EXP 6480464 2-hexenal results in increased expression of GSTA4 mRNA, 2-hexenal results in increased expression of GSTA4 protein CTD PMID:9799558 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of GSTA4 mRNA CTD PMID:28522335 4,4'-sulfonyldiphenol increases expression ISO RGD:1320601 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of GSTA4 protein CTD PMID:24793377 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of GSTA4 mRNA CTD PMID:9774145 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one decreases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of GSTA4 mRNA CTD PMID:9774145 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases activity EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of GSTA4 protein CTD PMID:9774145 4-hydroxynon-2-enal multiple interactions ISO RGD:1320601 6480464 GSTA4 protein binds to and affects the metabolism of 4-hydroxy-2-nonenal CTD PMID:15829614 4-hydroxynon-2-enal increases expression EXP 6480464 4-hydroxy-2-nonenal results in increased expression of GSTA4 mRNA, 4-hydroxy-2-nonenal results in increased expression of GSTA4 protein CTD PMID:9799558 4-hydroxynon-2-enal affects metabolic processing EXP 6480464 GSTA4 protein affects the metabolism of 4-hydroxy-2-nonenal, GSTA4 protein affects the metabolism of 4-hydroxy-2-nonenal analog CTD PMID:11256969 more ... 4-hydroxynon-2-enal affects metabolic processing ISO RGD:1320601 6480464 GSTA4 protein affects the metabolism of 4-hydroxy-2-nonenal CTD PMID:10514034 more ... 4-phenylbutyric acid increases expression ISO RGD:1320601 6480464 4-phenylbutyric acid results in increased expression of GSTA4 mRNA CTD PMID:14583596 5-aza-2'-deoxycytidine affects expression ISO RGD:1320601 6480464 Decitabine affects the expression of GSTA4 mRNA CTD PMID:23300844 5-fluorouracil affects response to substance ISO RGD:1320601 6480464 GSTA4 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of GSTA4 mRNA CTD PMID:24780913 acrolein increases expression EXP 6480464 Acrolein results in increased expression of GSTA4 mRNA, Acrolein results in increased expression of GSTA4 protein CTD PMID:9799558 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of GSTA4 mRNA CTD PMID:28959563 aflatoxin B1 affects response to substance ISO RGD:1320601 6480464 GSTA4 gene SNP affects the susceptibility to Aflatoxin B1 CTD PMID:12907637 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of GSTA4 mRNA CTD PMID:33354967 Allylamine decreases response to substance EXP 6480464 GSTA4 protein results in decreased susceptibility to Allylamine CTD PMID:10406932 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of GSTA4 mRNA CTD PMID:18178546 arsane multiple interactions ISO RGD:1320601 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GSTA4 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1320601 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GSTA4 mRNA CTD PMID:32525701 arsenite(3-) affects expression ISO RGD:1320601 6480464 arsenite affects the expression of GSTA4 mRNA CTD PMID:22959463 arsenite(3-) increases methylation ISO RGD:1320601 6480464 arsenite results in increased methylation of GSTA4 promoter CTD PMID:23974009 benzo[a]pyrene increases expression ISO RGD:1320601 6480464 Benzo(a)pyrene results in increased expression of GSTA4 mRNA CTD PMID:32890658 benzo[a]pyrene increases methylation ISO RGD:1320601 6480464 Benzo(a)pyrene results in increased methylation of GSTA4 5' UTR CTD PMID:27901495 beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of GSTA4 protein CTD PMID:9794803 bilirubin IXalpha decreases expression ISO RGD:1320601 6480464 Bilirubin results in decreased expression of GSTA4 mRNA CTD PMID:20196124 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GSTA4 mRNA CTD PMID:25181051 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GSTA4 mRNA CTD PMID:32145629 bisphenol A affects expression ISO RGD:1320601 6480464 bisphenol A affects the expression of GSTA4 mRNA CTD PMID:30903817 bucladesine increases expression ISO RGD:1320601 6480464 Bucladesine results in increased expression of GSTA4 mRNA CTD PMID:26049102 bucladesine multiple interactions ISO RGD:1320601 6480464 KT 5720 inhibits the reaction [Bucladesine results in increased expression of GSTA4 mRNA] CTD PMID:26049102 butyric acid increases expression ISO RGD:1320601 6480464 Butyric Acid results in increased expression of GSTA4 mRNA CTD PMID:30439556 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of GSTA4 protein CTD PMID:21699967 cadmium dichloride decreases expression ISO RGD:1320601 6480464 Cadmium Chloride results in decreased expression of GSTA4 protein CTD PMID:26220685 CGP 52608 multiple interactions ISO RGD:1320601 6480464 CGP 52608 promotes the reaction [RORA protein binds to GSTA4 gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions EXP 6480464 Chenodeoxycholic Acid binds to and results in decreased activity of GSTA4 protein CTD PMID:3954743 chenodeoxycholic acid multiple interactions ISO RGD:1320601 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of GSTA4 mRNA more ... CTD PMID:33819548 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of GSTA4 mRNA CTD PMID:30744511 chlorpyrifos affects expression EXP 6480464 Chlorpyrifos affects the expression of GSTA4 mRNA CTD PMID:19440498 chlorpyrifos decreases expression ISO RGD:1320601 6480464 Chlorpyrifos results in decreased expression of GSTA4 mRNA CTD PMID:33011216 cholic acid multiple interactions EXP 6480464 Cholic Acid binds to and results in decreased activity of GSTA4 protein CTD PMID:3954743 chromium(6+) decreases expression ISO RGD:1320601 6480464 chromium hexavalent ion results in decreased expression of GSTA4 mRNA CTD PMID:30690063 cisplatin affects expression ISO RGD:1320601 6480464 Cisplatin affects the expression of GSTA4 mRNA CTD PMID:23300844 cisplatin multiple interactions ISO RGD:1320601 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of GSTA4 mRNA CTD PMID:27392435 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of GSTA4 protein CTD PMID:20180811 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of GSTA4 protein CTD PMID:16470657 cobalt dichloride decreases expression ISO RGD:1320601 6480464 cobaltous chloride results in decreased expression of GSTA4 mRNA CTD PMID:19376846 copper atom multiple interactions ISO RGD:1320601 6480464 [NSC 689534 binds to Copper] which results in decreased expression of GSTA4 mRNA CTD PMID:20971185 copper atom increases expression EXP 6480464 Copper results in increased expression of GSTA4 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:1320601 6480464 [NSC 689534 binds to Copper] which results in decreased expression of GSTA4 mRNA CTD PMID:20971185 copper(0) increases expression EXP 6480464 Copper results in increased expression of GSTA4 mRNA CTD PMID:30556269 copper(II) sulfate decreases expression ISO RGD:1320601 6480464 Copper Sulfate results in decreased expression of GSTA4 mRNA CTD PMID:19549813 curcumin increases activity ISO RGD:1320601 6480464 Curcumin results in increased activity of GSTA4 protein CTD PMID:10514034 Cyanoginosin increases expression EXP 6480464 microcystin results in increased expression of GSTA4 mRNA CTD PMID:19135122 cyclosporin A decreases expression ISO RGD:1320601 6480464 Cyclosporine results in decreased expression of GSTA4 mRNA CTD PMID:20106945 more ... cypermethrin increases expression EXP 6480464 cypermethrin results in increased expression of GSTA4 mRNA CTD PMID:20815782 deoxycholic acid multiple interactions ISO RGD:1320601 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of GSTA4 mRNA more ... CTD PMID:33819548 Diallyl sulfide increases expression EXP 6480464 allyl sulfide results in increased expression of GSTA4 mRNA CTD PMID:19695238 diazinon decreases expression EXP 6480464 Diazinon results in decreased expression of GSTA4 mRNA CTD PMID:17452286 diazinon increases expression EXP 6480464 Diazinon results in increased expression of GSTA4 mRNA CTD PMID:19440498 dichlorine decreases expression EXP 6480464 Chlorine results in decreased expression of GSTA4 mRNA CTD PMID:18636392 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] affects the expression of GSTA4 mRNA CTD PMID:18636392 diclofenac decreases activity ISO RGD:1320601 6480464 Diclofenac results in decreased activity of GSTA4 protein CTD PMID:27183920 dicrotophos decreases expression ISO RGD:1320601 6480464 dicrotophos results in decreased expression of GSTA4 mRNA CTD PMID:28302478 dimethylarsinic acid increases expression ISO RGD:1320601 6480464 Cacodylic Acid results in increased expression of GSTA4 mRNA CTD PMID:17720352 dinophysistoxin 1 decreases expression ISO RGD:1320601 6480464 dinophysistoxin 1 results in decreased expression of GSTA4 mRNA CTD PMID:28939011 diuron increases expression EXP 6480464 Diuron results in increased expression of GSTA4 mRNA CTD PMID:21551480 doxorubicin affects response to substance ISO RGD:1320601 6480464 GSTA4 protein affects the susceptibility to Doxorubicin CTD PMID:18225754 doxorubicin decreases expression ISO RGD:1320601 6480464 Doxorubicin results in decreased expression of GSTA4 mRNA CTD PMID:29803840 ellagic acid increases expression ISO RGD:1320601 6480464 Ellagic Acid results in increased expression of GSTA4 mRNA CTD PMID:12002526 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of GSTA4 mRNA CTD PMID:29391264 etacrynic acid affects metabolic processing EXP 6480464 GSTA4 protein affects the metabolism of Ethacrynic Acid CTD PMID:2619714 etacrynic acid increases expression EXP 6480464 Ethacrynic Acid results in increased expression of GSTA4 mRNA, Ethacrynic Acid results in increased expression of GSTA4 protein CTD PMID:9799558 ethanol decreases expression ISO RGD:1320601 6480464 Ethanol results in decreased expression of GSTA4 mRNA CTD PMID:28986285 ethoxyquin increases expression EXP 6480464 Ethoxyquin results in increased expression of GSTA4 mRNA, Ethoxyquin results in increased expression of GSTA4 protein CTD PMID:19695238 , PMID:9794803 EUK-134 multiple interactions EXP 6480464 [Acetylcysteine co-treated with EUK-134] promotes the reaction [[Zinc Sulfate co-treated with Paraquat] results in increased activity of GSTA4 protein] more ... CTD PMID:25724285 fenitrothion multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Fenitrothion results in decreased expression of GSTA4 mRNA] CTD PMID:30639957 fenitrothion decreases expression EXP 6480464 Fenitrothion results in decreased expression of GSTA4 mRNA CTD PMID:30639957 fipronil increases expression EXP 6480464 fipronil results in increased expression of GSTA4 mRNA CTD PMID:23962444 flutamide increases expression EXP 6480464 Flutamide results in increased expression of GSTA4 mRNA CTD PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of GSTA4 mRNA CTD PMID:24793618 gamma-glutamyl-glutathione multiple interactions EXP 6480464 GSTA4 protein binds to and affects the metabolism of gamma-glutamyl-glutathione CTD PMID:2619714 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of GSTA4 protein CTD PMID:22061828 glutathione affects metabolic processing ISO RGD:1320601 6480464 GSTA4 protein affects the metabolism of Glutathione CTD PMID:14727915 glutathione multiple interactions ISO RGD:1320601 6480464 [GSTA4 protein co-treated with Glutathione] results in increased metabolism of amodiaquine quinoneimine, [GSTA4 protein co-treated with Glutathione] results in increased metabolism of desethylamodiaquine CTD PMID:28478157 glutathione affects metabolic processing EXP 6480464 GSTA4 protein affects the metabolism of Glutathione CTD PMID:14727915 glycochenodeoxycholic acid multiple interactions ISO RGD:1320601 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of GSTA4 mRNA more ... CTD PMID:33819548 glycocholic acid multiple interactions ISO RGD:1320601 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of GSTA4 mRNA more ... CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO RGD:1320601 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of GSTA4 mRNA more ... CTD PMID:33819548 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of GSTA4 mRNA CTD PMID:21396975 indole-3-methanol increases expression EXP 6480464 indole-3-carbinol results in increased expression of GSTA4 protein CTD PMID:9794803 inulin multiple interactions ISO RGD:1320601 6480464 [Inulin metabolite co-treated with oligofructose metabolite] results in increased expression of GSTA4 mRNA CTD PMID:23225440 iodide salt decreases expression EXP 6480464 Iodides deficiency results in decreased expression of GSTA4 protein CTD PMID:26795019 irinotecan affects expression EXP 6480464 Irinotecan affects the expression of GSTA4 mRNA CTD PMID:20097248 iron atom multiple interactions EXP 6480464 Iron results in increased expression of and results in increased activity of GSTA4 protein CTD PMID:7878679 iron(0) multiple interactions EXP 6480464 Iron results in increased expression of and results in increased activity of GSTA4 protein CTD PMID:7878679 kojic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTA4 mRNA CTD PMID:18544905 KT 5720 multiple interactions ISO RGD:1320601 6480464 KT 5720 inhibits the reaction [Bucladesine results in increased expression of GSTA4 mRNA] CTD PMID:26049102 L-ascorbic acid multiple interactions EXP 6480464 Ascorbic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of GSTA4 mRNA] CTD PMID:23470461 lead diacetate affects expression EXP 6480464 lead acetate affects the expression of GSTA4 mRNA CTD PMID:21864555 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of GSTA4 protein CTD PMID:7878682 , PMID:9750042 lead(0) decreases expression EXP 6480464 Lead results in decreased expression of GSTA4 protein CTD PMID:22129743 lead(0) affects splicing ISO RGD:1320601 6480464 Lead affects the splicing of GSTA4 mRNA CTD PMID:28903495 lead(0) multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [Lead results in decreased expression of GSTA4 protein] CTD PMID:22129743 leflunomide decreases expression ISO RGD:1320601 6480464 leflunomide results in decreased expression of GSTA4 mRNA CTD PMID:28988120 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of GSTA4 mRNA CTD PMID:24136188 lithium atom increases expression EXP 6480464 Lithium results in increased expression of GSTA4 mRNA CTD PMID:18082333 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of GSTA4 mRNA CTD PMID:18082333 lithocholic acid multiple interactions EXP 6480464 Lithocholic Acid binds to and results in decreased activity of GSTA4 protein CTD PMID:3954743 lithocholic acid increases expression EXP 6480464 Lithocholic Acid results in increased expression of GSTA4 mRNA CTD PMID:21311750 lithocholic acid sulfate multiple interactions EXP 6480464 sulfolithocholic acid binds to and results in decreased activity of GSTA4 protein CTD PMID:3954743 maneb increases activity EXP 6480464 Maneb results in increased activity of GSTA4 protein CTD PMID:20888808 maneb multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] results in increased expression of and results in increased activity of GSTA4 protein more ... CTD PMID:23159886 maneb increases expression EXP 6480464 Maneb results in increased expression of GSTA4 mRNA, Maneb results in increased expression of GSTA4 protein CTD PMID:20888808 , PMID:23159886 menadione affects expression ISO RGD:1320601 6480464 Vitamin K 3 affects the expression of GSTA4 mRNA CTD PMID:20044591 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of GSTA4 mRNA CTD PMID:30467583 methylmercury chloride decreases expression ISO RGD:1320601 6480464 methylmercuric chloride results in decreased expression of GSTA4 mRNA CTD PMID:28001369 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of GSTA4 mRNA CTD PMID:30744511 microcystin decreases expression EXP 6480464 Microcystins results in decreased expression of GSTA4 mRNA CTD PMID:19790251 microcystin increases expression EXP 6480464 Microcystins results in increased expression of GSTA4 mRNA CTD PMID:19790251 mono(2-ethylhexyl) phthalate decreases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of GSTA4 mRNA CTD PMID:22087261 N-acetyl-beta-D-glucosamine increases expression ISO RGD:1320601 6480464 Acetylglucosamine results in increased expression of GSTA4 mRNA CTD PMID:18047607 N-acetyl-D-glucosamine increases expression ISO RGD:1320601 6480464 Acetylglucosamine results in increased expression of GSTA4 mRNA CTD PMID:18047607 N-acetyl-L-cysteine multiple interactions EXP 6480464 [Acetylcysteine co-treated with EUK-134] promotes the reaction [[Zinc Sulfate co-treated with Paraquat] results in increased activity of GSTA4 protein] more ... CTD PMID:23159886 more ... N-hydroxy-PhIP increases expression EXP 6480464 2-hydroxyamino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of GSTA4 protein CTD PMID:17122891 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTA4 mRNA, [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of GSTA4 protein CTD PMID:18544905 , PMID:20935162 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of GSTA4 protein CTD PMID:19716841 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of GSTA4 mRNA CTD PMID:24136188 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of GSTA4 mRNA CTD PMID:9774145 nicotine increases expression EXP 6480464 Nicotine results in increased expression of GSTA4 mRNA CTD PMID:9774145 nicotine increases activity EXP 6480464 Nicotine results in increased activity of GSTA4 protein CTD PMID:9774145 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of GSTA4 mRNA CTD PMID:24136188 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of GSTA4 mRNA CTD PMID:33484710 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of GSTA4 mRNA CTD PMID:23358140 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of GSTA4 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of GSTA4 mRNA CTD PMID:25729387 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] affects the expression of GSTA4 mRNA CTD PMID:18636392 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of GSTA4 mRNA CTD PMID:27638505 paracetamol decreases expression ISO RGD:1320601 6480464 Acetaminophen results in decreased expression of GSTA4 mRNA CTD PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of GSTA4 mRNA CTD PMID:33387578 paracetamol multiple interactions ISO RGD:1320601 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of GSTA4 mRNA CTD PMID:33819548 paraquat multiple interactions EXP 6480464 [Acetylcysteine co-treated with EUK-134] promotes the reaction [[Zinc Sulfate co-treated with Paraquat] results in increased activity of GSTA4 protein] more ... CTD PMID:20553223 more ... paraquat increases activity EXP 6480464 Paraquat results in increased activity of GSTA4 protein CTD PMID:20888808 , PMID:25724285 paraquat increases expression EXP 6480464 Paraquat results in increased expression of GSTA4 mRNA, Paraquat results in increased expression of GSTA4 protein CTD PMID:20553223 more ... perfluorononanoic acid decreases expression ISO RGD:1320601 6480464 perfluoro-n-nonanoic acid results in decreased expression of GSTA4 mRNA CTD PMID:32588087 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of GSTA4 mRNA CTD PMID:19162173 phenobarbital decreases expression ISO RGD:1320601 6480464 Phenobarbital results in decreased expression of GSTA4 mRNA CTD PMID:19084549 phenobarbital multiple interactions EXP 6480464 [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of GSTA4 protein CTD PMID:20935162 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of GSTA4 mRNA, Phenobarbital results in increased expression of GSTA4 protein CTD PMID:19162173 , PMID:9794803 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in decreased expression of GSTA4 mRNA CTD PMID:33945839 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of GSTA4 mRNA CTD PMID:22484513 potassium chromate multiple interactions ISO RGD:1320601 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GSTA4 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1320601 6480464 potassium chromate(VI) results in decreased expression of GSTA4 mRNA CTD PMID:22079256 , PMID:22714537 potassium dichromate decreases expression EXP 6480464 Potassium Dichromate results in decreased expression of GSTA4 mRNA CTD PMID:23470461 potassium dichromate multiple interactions EXP 6480464 Ascorbic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of GSTA4 mRNA] CTD PMID:23470461 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of GSTA4 mRNA CTD PMID:19162173 pyrazinecarboxamide increases expression EXP 6480464 Pyrazinamide results in increased expression of GSTA4 mRNA CTD PMID:22431067 quercetin decreases expression ISO RGD:1320601 6480464 Quercetin results in decreased expression of GSTA4 mRNA CTD PMID:21632981 reactive oxygen species affects expression ISO RGD:1320601 6480464 Reactive Oxygen Species affects the expression of GSTA4 mRNA CTD PMID:25800948 resveratrol increases expression ISO RGD:1320601 6480464 resveratrol results in increased expression of GSTA4 mRNA CTD PMID:12002526 rotenone increases expression EXP 6480464 Rotenone results in increased expression of GSTA4 mRNA CTD PMID:28374803 sarin decreases expression ISO RGD:1320601 6480464 Sarin results in decreased expression of GSTA4 mRNA CTD PMID:19522546 senecionine decreases expression ISO RGD:1320601 6480464 senecionine results in decreased expression of GSTA4 mRNA CTD PMID:26100227 silicon dioxide decreases expression ISO RGD:1320601 6480464 Silicon Dioxide analog results in decreased expression of GSTA4 mRNA CTD PMID:25895662 silver atom decreases expression ISO RGD:1320601 6480464 Silver results in decreased expression of GSTA4 mRNA CTD PMID:26551752 silver(0) decreases expression ISO RGD:1320601 6480464 Silver results in decreased expression of GSTA4 mRNA CTD PMID:26551752 sodium arsenate multiple interactions ISO RGD:1320601 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GSTA4 mRNA CTD PMID:32525701 sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of GSTA4 mRNA CTD PMID:27257137 stilbene oxide increases expression EXP 6480464 stilbene oxide results in increased expression of GSTA4 protein CTD PMID:9794803 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of GSTA4 protein CTD PMID:14693714 sunitinib decreases expression ISO RGD:1320601 6480464 Sunitinib results in decreased expression of GSTA4 mRNA CTD PMID:31533062 Sunset Yellow FCF multiple interactions ISO RGD:1320601 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of GSTA4 mRNA CTD PMID:33819548 tartrazine multiple interactions ISO RGD:1320601 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of GSTA4 mRNA CTD PMID:33819548 temozolomide increases expression ISO RGD:1320601 6480464 Temozolomide results in increased expression of GSTA4 mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO RGD:1320601 6480464 tert-Butylhydroperoxide results in decreased expression of GSTA4 mRNA CTD PMID:15336504 , PMID:31627909 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GSTA4 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of GSTA4 mRNA CTD PMID:31150632 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of GSTA4 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of GSTA4 mRNA CTD PMID:25729387 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of GSTA4 mRNA CTD PMID:33387578 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of GSTA4 mRNA CTD PMID:30589522 urethane decreases expression ISO RGD:1320601 6480464 Urethane results in decreased expression of GSTA4 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1320601 6480464 Valproic Acid results in decreased expression of GSTA4 mRNA CTD PMID:23179753 valproic acid affects expression ISO RGD:1320601 6480464 Valproic Acid affects the expression of GSTA4 mRNA CTD PMID:25979313 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of GSTA4 mRNA CTD PMID:20566332 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of GSTA4 gene CTD PMID:31079544 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of GSTA4 mRNA CTD PMID:11717422 zinc sulfate multiple interactions EXP 6480464 [Acetylcysteine co-treated with EUK-134] promotes the reaction [[Zinc Sulfate co-treated with Paraquat] results in increased activity of GSTA4 protein] more ... CTD PMID:20553223 , PMID:25724285 zinc sulfate increases expression EXP 6480464 Zinc Sulfate results in increased expression of GSTA4 mRNA CTD PMID:20553223 , PMID:25724285 zinc sulfate increases activity EXP 6480464 Zinc Sulfate results in increased activity of GSTA4 protein CTD PMID:25724285 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of GSTA4 mRNA CTD PMID:11717422
